highperformr logo

CYTENA's Overview

Total employees67
HeadquartersFreiburg im Breisgau
Founded2014

Cytena GmbH, part of the BICO Group, is a leading life science company specializing in the development, manufacturing, and marketing of innovative single-cell isolation and handling technologies. Their solutions are crucial for applications such as cell line development, single-cell genomics, and proteomics, enabling researchers and scientists to advance drug discovery, personalized medicine, and bioprocessing. Cytena's instruments, like the c.sight™, f.sight™, and UP.SIGHT™, are renowned for their precision, speed, and gentle cell handling, ensuring cell viability and integrity. Acquired by BICO (formerly CELLINK) in 2019, Cytena continues to innovate within the bioconvergence landscape.

Where is CYTENA's Headquarters?

HQ Function

Serves as the primary center for research and development, manufacturing, global sales operations, and administrative functions for Cytena's single-cell technology portfolio.

Notable Features:

Modern laboratory and production facilities equipped for advanced biotechnology research, precision engineering, and instrument assembly.

Work Culture:

A dynamic and innovative environment driven by scientific excellence and engineering precision. Fosters collaboration, problem-solving, and a commitment to quality, reflecting both its German engineering heritage and its role within the forward-looking BICO group.

HQ Significance:

The Freiburg HQ is pivotal for Cytena's technological advancements in single-cell dispensing and is a key innovation and manufacturing site within the BICO group, contributing significantly to the field of bioconvergence.

Values Reflected in HQ: The headquarters reflects values of innovation, precision, quality, and customer-centricity, essential in the demanding life sciences and biotechnology sectors.

Location:

Cytena, as part of BICO, has a significant global footprint. Its operations are primarily centered in Europe (Germany HQ) and North America (USA office), with a growing presence in Asia-Pacific (China office). Globally, Cytena supports functions including R&D, manufacturing, direct sales, distribution partnerships, customer service, technical and application support. This international network allows Cytena to serve a diverse customer base in academia, pharmaceutical, and biotechnology industries worldwide.

Street Address:

Georges-Köhler-Allee 302

City:

Freiburg im Breisgau

State/Province:

Baden-Württemberg

Country:

Germany

CYTENA's Global Presence

Watertown, MA, USA

Address: c/o BICO, 100 Forge, 480 Arsenal St, Watertown, MA 02472, USA

To strengthen Cytena's presence in the key North American market, providing localized customer support and fostering collaborations to drive adoption of its single-cell technologies.

Shanghai, China

Address: c/o BICO China, Room 302, Building 2, Lane 588, Zixing Road, Minhang District, Shanghai, China

To expand market reach and provide tailored support to customers in the APAC region, adapting to local research needs and industry trends.

Gothenburg, Sweden

Address: c/o BICO Group HQ, Arvid Wallgrens Backe 20, 413 46 Gothenburg, Sweden

Integration with parent company operations, leveraging group synergies for R&D, market strategy, and global outreach.

Buying Intent Signals for CYTENA

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of CYTENA

As of April 2025, CYTENA' leadership includes:

Dr. Julian Riba - CEO, Cytena
Dr. André Gross - CSO (Chief Scientific Officer) & Co-founder, Cytena
Benjamin Steimle - CTO (Chief Technology Officer), Cytena
Jonas Umber - Head of Operations, Cytena

Investors of CYTENA

CYTENA has been backed by several prominent investors over the years, including:

BICO Group (formerly CELLINK) - Acquired Cytena in 2019, now parent company
High-Tech Gründerfonds (HTGF) - Early-stage seed investor (pre-acquisition)
KfW Bankengruppe - Early-stage investor (pre-acquisition)
Private Business Angels - Early-stage investors (pre-acquisition)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No specific high-profile Cytena executive hires or exits have been publicly announced in the last 12 months. Changes may occur within the broader BICO group that could influence subsidiary leadership. Cytena's core leadership team appears stable.

Technology (Tech Stack) used by CYTENA

Discover the tools CYTENA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

CYTENA Email Formats and Examples

Cytena likely utilizes common corporate email formats. Based on industry standards and practices within the BICO group, the most probable formats would involve combinations of first name, last name, or initials.

firstname.lastname@cytena.com or f.lastname@cytena.com

Format

john.doe@cytena.com

Example

80%

Success rate

News and media

BICO GroupMay 7, 2024

BICO Interim Report Q1 2024 Highlights Cytena's Performance

In BICO's Q1 2024 report, the Single-Cell Technologies division, prominently featuring Cytena, showed continued strong demand for consumables. The report noted a slight decline in instrument sales due to cautious capital expenditure but highlighted Cytena's overall positive contribution and strategic importance within the group....more

Cytena NewsNovember 15, 2023

Cytena Joins the ENABLE Consortium as an Associate Partner

Cytena announced its participation as an associate partner in the ENABLE (European Network for the Advancement of Lytic Bacteriophage Therapy) Consortium. This collaboration aims to advance phage therapy, with Cytena contributing its expertise in single-cell isolation to isolate and characterize bacteriophages....more

Cytena NewsAugust 25, 2022

CYTENA and CELLINK collaborate with an NCI-designated cancer center to advance cancer research with single-cell and bioprinting technologies

CYTENA and CELLINK announced a collaboration with the Comprehensive Cancer Center at Wake Forest Baptist, one of only 53 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the United States. This collaboration aims to accelerate cancer research by providing advanced single-cell isolation and bioprinting technologies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including CYTENA, are just a search away.